We are live on ! Find out more
PCP

Perbak Capital Partners Portfolio holdings

AUM $406M
1-Year Est. Return 17.25%
This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$406M
AUM Growth
+$78.6M
Cap. Flow
+$84.3M
Cap. Flow %
20.75%
Top 10 Hldgs %
44.54%
Holding
397
New
178
Increased
97
Reduced
19
Closed
103
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QLYS icon
276
Qualys
QLYS
$5.61B
$241K 0.06%
2,739
+48
+2% +$5.32K
ABCB icon
277
Ameris Bancorp
ABCB
$6.21B
$237K 0.06%
+3,035
New +$241K
CELC icon
278
Celcuity
CELC
$4.31B
$236K 0.06%
+2,071
New +$226K
MICC
279
The Magnum Ice Cream Company N.V.
MICC
$11.4B
$233K 0.06%
+15,564
New +$252K
WMG icon
280
Warner Music
WMG
$14.8B
$230K 0.06%
+9,000
New +$255K
ARWR icon
281
Arrowhead Research
ARWR
$10.5B
$229K 0.06%
+3,657
New +$231K
LKQ icon
282
LKQ Corp
LKQ
$6.47B
$217K 0.05%
+7,385
New +$237K
GGG icon
283
Graco
GGG
$12.4B
$216K 0.05%
+2,551
New +$226K
HYMC icon
284
Hycroft Mining Holding Corp
HYMC
$1.74B
$215K 0.05%
+6,098
New +$236K
TGTX icon
285
TG Therapeutics
TGTX
$8.4B
$214K 0.05%
+6,443
New +$192K
CRM icon
286
Salesforce
CRM
$140B
$212K 0.05%
+1,134
New +$235K
CPNG icon
287
Coupang
CPNG
$29.8B
$212K 0.05%
+11,203
New +$219K
KOF icon
288
Coca-Cola Femsa
KOF
$21.7B
$202K 0.05%
+2,075
New +$215K
HOMB icon
289
Home BancShares
HOMB
$6.18B
$201K 0.05%
+7,455
New +$210K
DHT icon
290
DHT Holdings
DHT
$2.8B
$191K 0.05%
10,442
-21,631
-67% -$345K
ADPT icon
291
Adaptive Biotechnologies
ADPT
$3.67B
$176K 0.04%
+12,645
New +$201K
TMC icon
292
TMC The Metals Company
TMC
$1.62B
$131K 0.03%
+27,963
New +$180K
GTM
293
ZoomInfo Technologies
GTM
$905M
$108K 0.03%
+18,101
New +$133K
CCC
294
CCC Intelligent Solutions
CCC
$3.55B
$90K 0.02%
15,001
-36,231
-71% -$237K
ABT icon
295
Abbott
ABT
$175B
-1,927
Closed -$241K
AGO icon
296
Assured Guaranty
AGO
$3.76B
-2,830
Closed -$254K
AKAM icon
297
Akamai
AKAM
$17.5B
-4,913
Closed -$429K
ALGN icon
298
Align Technology
ALGN
$12.7B
-2,256
Closed -$352K
AMP icon
299
Ameriprise Financial
AMP
$47.5B
-814
Closed -$399K
APLS
300
DELISTED
Apellis Pharmaceuticals
APLS
-10,217
Closed -$257K

Similar funds

Perbak Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Perbak Capital Partners held 397 positions worth $406M, up 24% from $328M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Perbak Capital Partners deployed $84.3M of net new capital in Q1 2026, opening 178 new positions and adding to 97 existing holdings. Its largest new stake was State Street Consumer Discretionary Select Sector SPDR ETF: 155,076 shares worth $16.9M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Invesco S&P 500 Equal Weight ETF, an estimated $52.8M trimmed.

  • Perbak Capital Partners's largest Q1 2026 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 155,076 shares worth $16.9M.
  • Perbak Capital Partners added most to State Street Industrial Select Sector SPDR ETF in Q1 2026, an estimated $37.4M increase.
  • Perbak Capital Partners's biggest Q1 2026 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $52.8M.
  • Perbak Capital Partners fully exited State Street SPDR S&P Retail ETF in Q1 2026, selling an estimated $4.49M.
  • Perbak Capital Partners's ten largest holdings make up 45% of its $406M portfolio in Q1 2026.
  • Perbak Capital Partners opened 178 new positions and closed 103 in Q1 2026.
  • Perbak Capital Partners's portfolio value rose 24% quarter-over-quarter to $406M.

Based on Perbak Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.